Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > HG NMIBC & CIS HG NMIBC...?????

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon May 29, 2023 12:15pm

240 Views

Post# 35468825

RE:HG NMIBC & CIS HG NMIBC...?????

I would think that NRs, conference posters and the AUA interview would have been pulpits to shout out this message, if tumors went from HG with CIS to "just" HG. Strange that they haven't called this out, if true. 100% safe, 100% downgrade from CIS for all responders and a 30% CR at 450D would be a no brainer to approve.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China